JY
OPRX icon

Jeff Yass’s OptimizeRx OPRX Stock Holding History

Jeff Yass’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$219K Sell
38,200
-10,100
-21% -$58.1K ﹤0.01% 11759
2026
Q1 		$303K Buy
+48,300
New +$449K ﹤0.01% 10829
2025
Q4 		– Sell
-31,100
Closed -$638K – 13238
2025
Q3 		$638K Buy
+31,100
New +$493K ﹤0.01% 8417
2025
Q2 		– Sell
-24,200
Closed -$210K – 13434
2025
Q1 		$210K Buy
+24,200
New +$148K ﹤0.01% 10835
2024
Q3 		– Sell
-10,100
Closed -$101K – 12740
2024
Q2 		$101K Buy
+10,100
New +$111K ﹤0.01% 11026
2023
Q2 		– Sell
-14,500
Closed -$212K – 12836
2023
Q1 		$212K Buy
+14,500
New +$243K ﹤0.01% 10471
2022
Q4 		– Sell
-29,500
Closed -$437K – 13324
2022
Q3 		$437K Buy
+29,500
New +$583K ﹤0.01% 8840
2022
Q2 		– Sell
-17,600
Closed -$664K – 13640
2022
Q1 		$664K Sell
17,600
-11,100
-39% -$491K ﹤0.01% 8222
2021
Q4 		$1.78M Sell
28,700
-48,800
-63% -$3.7M ﹤0.01% 5780
2021
Q3 		$6.63M Sell
77,500
-118,600
-60% -$7.44M ﹤0.01% 3487
2021
Q2 		$12.1M Buy
196,100
+133,900
+215% +$6.81M ﹤0.01% 2646
2021
Q1 		$3.03M Buy
62,200
+12,900
+26% +$622K ﹤0.01% 4923
2020
Q4 		$1.54M Buy
+49,300
New +$1.21M ﹤0.01% 5691
2020
Q2 		– Sell
-74,000
Closed -$670K – 10686
2020
Q1 		$670K Buy
+74,000
New +$702K ﹤0.01% 6294
2019
Q4 		– Sell
-41,300
Closed -$598K – 10375
2019
Q3 		$598K Buy
41,300
+16,700
+68% +$258K ﹤0.01% 6880
2019
Q2 		$399K Buy
+24,600
New +$332K ﹤0.01% 7743

Other funds holding OPRX

WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Jeff Yass's OPRX Position: Q2 2026 in Review

Jeff Yass increased its OptimizeRx (OPRX) stake by 243% in Q2 2026, buying an estimated $159K and bringing the position to 39,003 shares worth $223K. The position accounts for ﹤0.01% of the portfolio, ranked #11708.

Jeff Yass first reported a position in OPRX in Q4 2018 and has held it in 17 quarters since. The position peaked at $2.95M in Q1 2023. 112 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

  • Jeff Yass held 39,003 shares of OptimizeRx worth $223K as of Q2 2026.
  • Jeff Yass bought 27,630 OptimizeRx shares in Q2 2026, an estimated $159K.
  • OptimizeRx made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #11708 holding.
  • Jeff Yass first reported a position in OptimizeRx in Q4 2018 and has held it in 17 quarters since.
  • Jeff Yass's OptimizeRx position peaked at $2.95M in Q1 2023.
  • 112 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.